Proteomics of neurodegenerative diseases: analysis of human post-mortem brain.


Journal

Journal of neurochemistry
ISSN: 1471-4159
Titre abrégé: J Neurochem
Pays: England
ID NLM: 2985190R

Informations de publication

Date de publication:
11 2019
Historique:
received: 05 06 2018
revised: 15 08 2018
accepted: 01 10 2018
pubmed: 6 10 2018
medline: 6 5 2020
entrez: 6 10 2018
Statut: ppublish

Résumé

Dementias are prevalent brain disorders in the aged population. Dementias pose major socio-medical burden, but currently there is no cure available. Novel proteomics approaches hold promise to identify alterations of the brain proteome that could provide clues on disease etiology, and identify candidate proteins to develop further as a biomarker. In this review, we focus on recent proteomics findings from brains affected with Alzheimer's Disease, Parkinson Disease Dementia, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis. These studies confirmed known cellular changes, and in addition identified novel proteins that may underlie distinct aspects of the diseases. This article is part of the special issue "Proteomics".

Identifiants

pubmed: 30289976
doi: 10.1111/jnc.14603
pmc: PMC6899881
doi:

Substances chimiques

Biomarkers 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-445

Informations de copyright

© 2018 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.

Références

J Neuropathol Exp Neurol. 2012 May;71(5):362-81
pubmed: 22487856
Curr Alzheimer Res. 2011 May;8(3):273-94
pubmed: 21222600
Mol Neurodegener. 2017 Nov 10;12(1):83
pubmed: 29126445
Expert Rev Proteomics. 2017 Nov;14(11):1007-1020
pubmed: 28942688
Alzheimers Dement. 2017 Sep;13(9):965-984
pubmed: 28341160
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6526-E6534
pubmed: 27708157
J Alzheimers Dis. 2014;42(1):157-67
pubmed: 24820015
Alzheimers Dement (Amst). 2016 Jan 19;2:86-94
pubmed: 27239539
J Neurol Sci. 2007 Jun 15;257(1-2):72-9
pubmed: 17303173
Am J Hum Genet. 2017 Jul 6;101(1):5-22
pubmed: 28686856
Nat Neurosci. 2015 Aug;18(8):1183-9
pubmed: 26192747
Neurology. 1991 Apr;41(4):479-86
pubmed: 2011243
Expert Rev Proteomics. 2016 Sep;13(9):845-55
pubmed: 27477319
J Proteome Res. 2013 Mar 1;12(3):1377-86
pubmed: 23323968
Methods Mol Biol. 2018;1723:371-383
pubmed: 29344872
Brain. 2018 Jun 1;141(6):1828-1839
pubmed: 29672664
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Cell Syst. 2017 Jun 28;4(6):587-599.e4
pubmed: 28601559
Nat Commun. 2018 Feb 13;9(1):490
pubmed: 29440659
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006189
pubmed: 22229116
J Pathol. 2017 Sep;243(1):78-88
pubmed: 28657654
J Neuropathol Exp Neurol. 2000 Aug;59(8):733-48
pubmed: 10952063
Acta Neuropathol. 2017 Aug;134(2):187-205
pubmed: 28401333
Acta Neuropathol Commun. 2018 Jun 4;6(1):46
pubmed: 29860944
J Proteome Res. 2014 Apr 4;13(4):2056-68
pubmed: 24606058
Brain. 2018 Feb 1;141(2):582-595
pubmed: 29324989
J Proteome Res. 2015 Dec 4;14(12):5378-87
pubmed: 26538118
Proteomics. 2015 Jan;15(2-3):508-519
pubmed: 25332170
Nature. 2006 Oct 19;443(7113):780-6
pubmed: 17051204
Nat Commun. 2017 Oct 31;8(1):1214
pubmed: 29089479
Neuron. 2017 Nov 1;96(3):558-571
pubmed: 29096073
J Proteome Res. 2018 Jan 5;17(1):727-738
pubmed: 29183128
Mol Cell Proteomics. 2016 Feb;15(2):409-25
pubmed: 26657538
Mol Neurobiol. 2016 Jan;53(1):379-390
pubmed: 25452228
Drugs Aging. 2001;18(6):397-407
pubmed: 11419914
Brain. 2017 Feb;140(2):266-278
pubmed: 27658420
Acta Neuropathol Commun. 2018 Apr 3;6(1):26
pubmed: 29615128
Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):E6962-E6971
pubmed: 28701379
Eur J Hum Genet. 2017 Aug;25(8):973-981
pubmed: 28537274
Immunity. 2017 Sep 19;47(3):566-581.e9
pubmed: 28930663
PLoS One. 2016 Mar 07;11(3):e0150672
pubmed: 26950848
Brain. 2000 Mar;123 Pt 3:484-98
pubmed: 10686172
Proteomics. 2018 Jan;18(1):
pubmed: 29134766
J Alzheimers Dis. 2018;62(3):1125-1140
pubmed: 29562534
PLoS Genet. 2011 Feb;7(2):e1001308
pubmed: 21379329
Brain Pathol. 2018 Nov;28(6):965-985
pubmed: 29396893
Nat Genet. 2017 Sep;49(9):1373-1384
pubmed: 28714976
Nat Rev Dis Primers. 2017 Mar 23;3:17013
pubmed: 28332488
J Clin Invest. 2003 Jan;111(1):3-10
pubmed: 12511579
Oncotarget. 2015 Nov 24;6(37):39437-56
pubmed: 26517091
Neurosci Bull. 2016 Apr;32(2):183-90
pubmed: 26810783
Elife. 2017 Nov 09;6:
pubmed: 29120328
Methods Mol Biol. 2018;1711:133-148
pubmed: 29344888
Biochim Biophys Acta. 2009 Jul;1792(7):730-40
pubmed: 18718530
Acta Neuropathol Commun. 2018 Jul 23;6(1):64
pubmed: 30037350
Neurochem Res. 2012 Dec;37(12):2805-13
pubmed: 22926577
Mol Neurobiol. 2018 Jan;55(1):370-381
pubmed: 28004338
Mol Psychiatry. 2018 Nov;23(11):2133-2144
pubmed: 29311653
Proteomics Clin Appl. 2012 Apr;6(3-4):201-11
pubmed: 22532456
OMICS. 2018 Jan;22(1):1-16
pubmed: 29356624
Mol Brain. 2017 Aug 11;10(1):36
pubmed: 28800743
Neuropathol Appl Neurobiol. 2011 Feb;37(1):75-93
pubmed: 20946241
Acta Neuropathol. 2017 Jun;133(6):933-954
pubmed: 28258398
JAMA. 2010 May 12;303(18):1832-40
pubmed: 20460622
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Commun Biol. 2019 Feb 4;2:43
pubmed: 30729181
Acta Neuropathol. 2017 Oct;134(4):605-617
pubmed: 28478503
Clin Chim Acta. 2013 May;420:62-8
pubmed: 23537733
Anal Chem. 2018 Mar 6;90(5):2979-2986
pubmed: 29384654
EMBO Mol Med. 2018 Jan;10(1):48-62
pubmed: 29191947
Neuropathol Appl Neurobiol. 2017 Oct;43(6):492-504
pubmed: 27543695
Neuropathol Appl Neurobiol. 2017 Jun;43(4):281-298
pubmed: 27442752
Acta Neuropathol Commun. 2014 Jun 29;2:76
pubmed: 24974208
Brain Pathol. 2017 Sep;27(5):645-674
pubmed: 28804999
Nat Neurosci. 2018 Mar;21(3):424-431
pubmed: 29403032
Alzheimers Dement. 2012 Jan;8(1):1-13
pubmed: 22265587
Brain Res Bull. 2016 Mar;121:98-104
pubmed: 26791740
J Stroke. 2015 Jan;17(1):17-30
pubmed: 25692104
J Biol Chem. 2012 Jun 1;287(23):19440-51
pubmed: 22461630
J Proteomics. 2017 May 24;161:11-25
pubmed: 28396268
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
Alzheimers Dement. 2016 Jun;12(6):654-68
pubmed: 26772638
Nature. 2004 Aug 5;430(7000):631-9
pubmed: 15295589
Cell Syst. 2017 Jan 25;4(1):60-72.e4
pubmed: 27989508
Sci Rep. 2017 Aug 22;7(1):9115
pubmed: 28831118

Auteurs

K W Li (KW)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, The Netherlands.

Andrea B Ganz (AB)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, The Netherlands.

August B Smit (AB)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH